• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    CMS Establishes New Payment for Pelvalon’s Eclipse System

    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy

    Resonetics Leases New Manufacturing Space in Costa Rica

    Seisa Medical Acquires ProtoQuick and Peridot

    Masimo Device is Useful in Assessing Respiratory Status of Pediatric Tracheostomy Patients
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Unicep

    Medbio LLC

    Creganna Medical, part of TE Connectivity

    PTI Engineered Plastics Inc.

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing

    Digging into the Cardiac Arrhythmia Monitoring Device Market

    EMS Providers Supplying More Than Electronics to Customers
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Concise Engineering

    Medicoil

    Medbio LLC

    maxon

    Forefront Medical Technology
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Extractable/Leachable Chemistry Testing Strategies for Medical Devices

    ...

    Extractable/Leachable Chemistry Testing Strategies for Medical Devices
    Medical device extracts prepared for analysis. Image courtesy of Nelson Laboratories.
    Related CONTENT
    • Biomechanical Engineer, Heal Thyself
    • Optimizing MIM in Medical Device Manufacturing
    • PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    • The Evolution of Chemical Characterization for Medical Devices
    • Ethicon Launches Echelon+ Stapler
    Matthew R Jorgensen, Ph.D., and Thor Rollins, BS, Nelson Laboratories; Allison Komiyama, Ph.D., RAC, AcKnowledge RS04.03.17
    It has become more prevalent and acceptable to use the results of chemistry testing to assess the overall biocompatibility of medical devices. For many devices with prolonged or permanent patient contact, chemistry followed by toxicological assessment can provide a cost and time saving alternative to in vivo tests such as chronic, sub-chronic, genetic, and carcinogenicity testing. Manufacturers preparing to submit their device for approval by the U.S. Food and Drug Administration (FDA) rely on ISO 10993 standards and FDA guidance on the application of those standards in the planning of their chemistry testing. When it comes to the details of chemistry testing, however, the ISO standards are often vague. Furthermore, the recommendations regarding the appropriate level of testing rigor can vary within FDA. The following offers a brief overview of the framework provided by ISO 10993 guidance documents for extractable/leachable (E/L) testing, as well as three testing strategies that satisfy both ISO 10993 and FDA requirements.

    There are three parts of ISO 10993 that are applicable to E/L testing:

    • 10993-12: How to prepare the sample—Defines what an extractable is versus a leachable, the criteria for exhaustive extraction, recommendations on extraction volume and extraction vehicles (polar and non-polar).
    • 10993-18 (BE83:2006/(R)2011): How to analyze the sample—Provides general guidance on the types of analytical instruments appropriate for identification and quantification of different analytes.
    • 10993-17: How to interpret the results—Provides guidance on how to establish allowable limits (tolerable exposures) for substances extracted from medical devices.
    The first step in setting a testing strategy is to establish the goals of the testing and assessment. Typically, the goal of E/L testing is to identify any substance that could leave the device and enter the body, followed by an assessment of whether the substance(s) could result in toxicity to the patient. Therefore, the tests performed should screen for as many compounds as possible, quantify any E/L compounds, and ensure sufficient material is available for assessment.

    Considering that devices commonly contain (intentionally or not) both polar and non-polar substances, and the body is composed of both polar and non-polar fluids and membranes, extraction with both polar and non-polar solvents is required. Water or saline as the polar extraction vehicle and hexane as the non-polar extraction vehicle are commonly accepted choices.

    Although E/L is often used as a substitute for long-term in vivo biocompatibility tests, results are generally considered concurrently with other tests such as cytotoxicity, sensitization, and irritation. To allow comparison to these other tests, similar extraction conditions are recommended, which represent worse-case conditions per ISO 10993-12. Extraction at 50 degrees Celsius for 72 hours is a common first choice. If follow-up testing is required, other conditions more representative of clinical use can be used with justification. Extraction volume should be selected to meet several conditions: the volume should be small enough (resulting in a concentration that is high enough) so the sensitivity of the analysis in terms of µg of analyte per device is acceptable. Additionally, the extraction volume per device should be the same or less than what was used for biocompatibility testing, but still provides enough volume to be practical for all the required analytical tests.

    As mentioned previously, the analysis should screen for as many compounds as possible, as it can be difficult to predict what substances could be on or in a device before analysis. To that end, the analysis should look for both organic and inorganic compounds, be able to identify these compounds, and be able to measure their concentration. Mass spectrometry methods are able to do all of these. Inductively coupled plasma mass spectrometry (ICP/MS) identifies and measures metals (which addresses inorganic compounds), while gas chromatography mass spectrometry (GC/MS) methods identify different classes of organic compounds (provided the molecules are not too large), and liquid chromatography mass spectrometry is used to screen for any organic molecules too large for GC/MS. Therefore, to cast as wide a net as possible, the extracts and their blanks should be analyzed using each of these methods. For a single device, analysis of four liquid samples is involved (one polar, one non-polar, and two blanks), creating a total of 12 mass spectrometry analyses per device. A typical testing matrix is shown in Table 1.


    The analysis in Table 1 represents the most basic E/L analysis strategy: two solvents and two blanks, undergoing a total of 12 analytical tests. Recently, the FDA has requested variations on this analytical strategy that result in increased rigor of the analysis. For example, there have been requests for the addition of a third mid-polarity solvent, such as isopropanol, for the analysis to be repeated in triplicate, or for exhaustive extraction methods to be used. Exhaustive extraction involves repeating the basic extraction and analysis until the currently detected extracts are less than 10 percent of the sum of all extracts; this strategy involves, at a minimum, two analyses but could include more. These strategies are compared in Table 2.


    The cost and turn-around time of E/L testing depends on the lab, but generally scales with the number of analytical tests requested or required. Practices and level of rigor can vary widely in labs performing E/L testing due to the ambiguity of ISO 10993-18. It is critical to determine if the level of rigor meets what is required for toxicological risk assessment per ISO 10993-17. One of the largest variables is whether detected analytes are rigorously quantitated or if they have concentrations that are estimated using semi-quantitative methods. Often, the reality is a combination of both. For example, a lab may report some analytes quantitatively if they are on a panel of common compounds, but only estimate others in a single report. For each analytical method used by a lab, the level of method validation can also vary. Questions of analytical rigor come into play when the chemistry results are interpreted by a toxicologist. If the expert interpreting the results is skilled, they may notice deficiencies in the analytical methodology and be unable to draw a conclusion or make a recommendation other than “more chemistry testing is needed.”

    Selection of a testing strategy should be primarily based upon any specific feedback received from FDA. If no feedback is available, several factors should be considered: the device type, the nature and duration of patient contact, how conservative of an approach is desired, and the cost. FDA may request E/L testing above and beyond the typically required biocompatibility program. For example, we have seen requests for E/L on devices with brightly colored parts, especially when the targeted patient population includes neonates or other sensitive groups. There has also been a trend in requests for exhaustive E/L testing from FDA for devices with respiratory patient contact.

    Approaching E/L chemistry testing can be a daunting task to the uninitiated; there are many variables and the guidance provided by the ISO 10993 standards and FDA is vague. However, a basic analytical protocol (shown in Table 1) has been widely accepted along with extraction conditions that mirror those familiar to biocompatibility testing. Ultimately, the most sure-fire approach is to develop a testing plan in collaboration with the toxicologist interpreting the results and FDA. The recently released FDA guidance document on the use of ISO 10993 stresses the importance of a written biocompatibility evaluation plan (BEP). In this plan, the potential risks of the device should be discussed, as well as the approaches to address the potential risks. The BEP is an excellent place to outline the strategy proposed for E/L chemical analysis and allow FDA to review and comment on the plan as part of a pre-submission conversation. With a nod of approval from FDA and the toxicologist, you can proceed confidently into the world of chemistry. 


    Matthew R. Jorgensen, Ph.D., is a chemistry and materials scientist with Nelson Laboratories. Thor Rollins, B.S., RN (NRCM) is a senior scientist with the company. Allison Komiyama, Ph.D., RAC, is owner and principal consultant at AcKnowledge Regulatory Strategies. 
    Related Searches
    • patient
    • micro
    • it
    • u.s. food and drug administration
    Related Knowledge Center
    • Testing
    Suggested For You
    Biomechanical Engineer, Heal Thyself Biomechanical Engineer, Heal Thyself
    Optimizing MIM in Medical Device Manufacturing Optimizing MIM in Medical Device Manufacturing
    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    The Evolution of Chemical Characterization for Medical Devices The Evolution of Chemical Characterization for Medical Devices
    Ethicon Launches Echelon+ Stapler Ethicon Launches Echelon+ Stapler
    Outward Appearance: Reviewing Surface Treatment Options Outward Appearance: Reviewing Surface Treatment Options
     BD Gains EUA for Asymptomatic COVID-19 Screening via Rapid Testing BD Gains EUA for Asymptomatic COVID-19 Screening via Rapid Testing
    Abbott Abbott's Rapid COVID-19 Self-Test Receives EUA
    Bassetti Acquires 3DTRUST Bassetti Acquires 3DTRUST
    Alaxo Airway Stents Establishes Partnership With Portage College Alaxo Airway Stents Establishes Partnership With Portage College
    Diagnosing the IVD Market: An Interview with TEAM Technologies Diagnosing the IVD Market: An Interview with TEAM Technologies
    Harnessing Critical Health Data With Wearable Technology Harnessing Critical Health Data With Wearable Technology
    5 Ways Manufacturers Can Improve IoMT Device Security 5 Ways Manufacturers Can Improve IoMT Device Security
    Olympic Bobsledder Named New Board Chairman at PathogenX Olympic Bobsledder Named New Board Chairman at PathogenX
    Medical Device Supply Chain: At What Stage of a Product’s Lifecycle Should You Bring in a CM Partner Medical Device Supply Chain: At What Stage of a Product’s Lifecycle Should You Bring in a CM Partner

    Related Columns

    • Testing
      The Evolution of Chemical Characterization for Medical Devices

      The Evolution of Chemical Characterization for Medical Devices

      Evaluation of biological safety of devices is experiencing some of the most significant changes in history.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Medical Device Testing 04.01.21

    • Testing
      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Companies need to review their testing plan so it supports a successful submission, saves time, and ensures the long-term success of their product.
      Sherry Parker, Ph.D., Senior Director of Regulatory Toxicology, WuXi AppTec Medical Device Testing 06.04.20

    • Testing
      The Importance of Usability/Human Factors Testing

      The Importance of Usability/Human Factors Testing

      When is the work of human factors over, and how does your team know they are prepared for summative testing?
      Maria Shepherd, President and Founder, Medi-Vantage 03.04.20


    • Materials | Testing
      Particle Particulars: Why this Analysis Is Foundational for Successful Devices

      Particle Particulars: Why this Analysis Is Foundational for Successful Devices

      In the mid-2000s, medical device experts were hopeful they’d found one solution to longer-lasting implants.
      Dawn A. Lissy, President & Founder, Empirical 03.04.20

    • R&D & Design | Testing
      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      Different materials exhibit different radiopacity as a function of material composition (i.e. atomic weight) and thickness.
      Gil Zweig, President, Glenbrook Technologies 01.29.20

    • Testing
      Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971

      Managing Risks for Medical Devices: A Guide to Understanding ISO 14971

      The intent of ISO 14971 is to provide a general “bird’s-eye view” approach to designing and implementing a risk management plan for medical devices.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Labs 10.08.19


    • Testing
      Preparing for MDR: Test In-House or Outsource?

      Preparing for MDR: Test In-House or Outsource?

      As the EU MDR deadline draws near, manufacturers are under pressure to bring products into compliance and get submissions in front of regulators ASAP.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi Medical Device Testing 10.08.19

    • Testing
      Why Big Companies With Internal Labs Should Outsource Testing

      Why Big Companies With Internal Labs Should Outsource Testing

      ...
      Dawn A. Lissy, President & Founder, Empirical 03.07.19

    • Packaging & Sterilization | Testing
      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      ...
      Dawn A. Lissy, President & Founder, Empirical 07.26.18


    • 3D/Additive Manufacturing | Testing
      The Final Four: My Top Headlines for 2017

      The Final Four: My Top Headlines for 2017

      ...
      Dawn A. Lissy, President & Founder, Empirical 11.07.17

    • Packaging & Sterilization | Testing
      Packaging Validations—Looking Beyond ISO 11607

      Packaging Validations—Looking Beyond ISO 11607

      ...
      Christopher Scott, Vice President, Eurofins Medical Device Testing 10.05.17

    • Testing
      So We’re All on the Same Page: You Need a Test Plan

      So We’re All on the Same Page: You Need a Test Plan

      ...
      Dawn A. Lissy, Empirical 09.01.17


    • 3D/Additive Manufacturing | R&D & Design | Testing
      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      ...
      Dawn A. Lissy, Empirical 07.26.17

    • Digital Health | Software & IT | Testing
      Recent Cyber Attack Enough to Make Medtech WannaCry

      Recent Cyber Attack Enough to Make Medtech WannaCry

      ...
      Michael Barbella, Managing Editor 06.06.17

    • R&D & Design | Testing
      The Human Factor

      The Human Factor

      ...
      Steve Maylish and Dave Hines, Fusion Biotec 05.01.17


    Trending
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Face Mask Filters 98 Percent Of COVID-19 Particles
    • Cheetah Medical Introduces Noninvasive Monitoring System
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • CMS Establishes New Payment for Pelvalon’s Eclipse System
    • Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    • Resonetics Leases New Manufacturing Space in Costa Rica
    • Seisa Medical Acquires ProtoQuick and Peridot
    • Masimo Device is Useful in Assessing Respiratory Status of Pediatric Tracheostomy Patients
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies to Sponsor and Exhibit at the North American Pultrusion Conference 2021
    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    The Honest Company Files for IPO
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login